Trusted Resources: Education
Scientific literature and patient education texts
Novel Subtype of Mucopolysaccharidosis Caused by Arylsulfatase K (ARSK) Deficiency
source: Journal of medical genetics
year: 2021
authors: Verheyen S,Blatterer J,Speicher MR,Bhavani GS,Boons GJ,Ilse MB,Andrae D,Sproß J,Vaz FM,Kircher SG,Posch-Pertl L,Baumgartner D,Lübke T,Shah H,Al Kaissi A,Girisha KM,Plecko B
summary/abstract:Mucopolysaccharidoses (MPS) are monogenic metabolic disorders that significantly affect the skeleton. Eleven enzyme defects in the lysosomal degradation of glycosaminoglycans (GAGs) have been assigned to the known MPS subtypes (I-IX). Arylsulfatase K (ARSK) is a recently characterised lysosomal hydrolase involved in GAG degradation that removes the 2-O-sulfate group from 2-sulfoglucuronate. Knockout of in mice was consistent with mild storage pathology, but no human phenotype has yet been described.
organization: Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria.DOI: 10.1136/jmedgenet-2021-108061
read more
BookmarkRelated Content
-
Boston Children’s – Lysosomal Storage Disease Program (BoLD)The Boston Children's Lysosomal Storage ...
-
Hearing Loss in MucopolysaccharidosisIntroduction: Mucopolysaccharidosis (MPS...
-
Mucopolysaccharidosis Type 1 (MPS 1)What is Mucopolysaccharidosis Type 1?Muc...
-
Ultrasound Findings of Finger, Wrist and Knee Joints in Mucopolysaccharidosis Type IMusculoskeletal findings in MPS can prog...
-
Magnetic Resonance Imaging Findings of the Posterior Fossa in 47 Patients With Mucopolysaccharidoses: A Cross-Sectio...Mucopolysaccharidoses (MPS) is a group o...
-
Facial and Cephalometric Features of Individuals With Mucopolysaccharidosis: A Cross-Sectional StudyThe aim was to assess craniofacial featu...
-
Advocacy for MPS and MLAdvocacy is the best way for the MPS and...
Powered by
